Dr. Stuart D. Katz has been named the new Director of the NYU-Langone Medical Center Heart Failure Program. Dr. Katz will also serve as the first Helen L. and Martin S. Kimmel Professor of Advanced Cardiac Therapeutics. Joining us from Yale University, where he has served as director of their Heart Failure/Transplantation Program, Dr. Katz is a nationally prominent NIH-funded investigator, who has focused his career on patient-oriented clinical research and education. He has made major contributions to our understanding of endothelial dysfunction in patients with heart failure and more recently, he is investigating the biological effects of iron stores on vascular function and potential clinical applications of erythropoietin in acute coronary syndromes. In addition, Dr. Katz has also devoted substantial effort to mentoring junior faculty pursuing clinical research careers.
Dr. Katz will work closely with our cardiovascular experts, both medical and surgical, to establish a multi-disciplinary program that focuses on innovative strategies for the treatment of heart failure. He also will collaborate with basic and translational investigators to explore novel gene, cellular and device-based therapies for patients with cardiovascular disease.
Dr. Katz is available for outpatient consultations for individuals with known or suspected heart failure and/or cardiomyopathy, including pre-transplantation evaluations. Patients will be seen in our new Cardiology Faculty Group Practice Suite, Skirball-9R.
For appointments, call 212-263-7751.